KEY FEATURES
| Full Name | Transforming Growth Factor Beta Receptor I |
|---|---|
| Synonym | ACVRLK4; AAT5; ALK5; SKR4; TGFR-1; Activin A Receptor Type II-Like Kinase 53kDa; Activin receptor-like kinase 5; Serine/threonine-protein kinase receptor R4 |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse TGFbR1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse TGFbR1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse TGFbR1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse TGFbR1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse TGFbR1. You can calculate the concentration of Mouse TGFbR1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse TGFbR1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.52 | 1.04 | 3.95 | 0.56 | 1 | 3.89 |
| Standard deviation | 0.03 | 0.06 | 0.12 | 0.03 | 0.05 | 0.17 |
| CV(%) | 5.14 | 5.57 | 3.06 | 5.06 | 4.95 | 4.39 |
RECOVERY
The recovery of Mouse TGFbR1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 90-101 | 96 |
| EDTA plasma (n=8) | 88-100 | 93 |
| Cell culture media (n=8) | 86-100 | 93 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse TGFbR1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with TGFBR1 ELISA Kits
| TGFBR2 ELISA Kit | publications with TGFBR1 and TGFBR2 |
| TGFB1 ELISA Kit | publications with TGFBR1 and TGFB1 |
| SMAD2 ELISA Kit | publications with TGFBR1 and SMAD2 |
| SMAD7 ELISA Kit | publications with TGFBR1 and SMAD7 |
| SMAD4 ELISA Kit | publications with TGFBR1 and SMAD4 |
| TGFB3 ELISA Kit | publications with TGFBR1 and TGFB3 |
| SMURF2 ELISA Kit | publications with TGFBR1 and SMURF2 |
| UBC ELISA Kit | publications with TGFBR1 and UBC |
Pathways associated with TGFBR1 ELISA Kit
| ALK1 Signaling Events Pathway | ALK1 Signaling Events Pathway |
| Adherens Junction Pathway | Adherens Junction Pathway |
| Chagas Disease (American Trypanosomiasis) Pathway | Chagas Disease (American Trypanosomiasis) Pathway |
| Chronic Myeloid Leukemia Pathway | Chronic Myeloid Leukemia Pathway |
| Colorectal Cancer Pathway | Colorectal Cancer Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
Diseases associated with TGFBR1 ELISA Kit
| Loeys-Dietz Syndrome | publications with TGFBR1 and Loeys-Dietz Syndrome |
| Heart Diseases | publications with TGFBR1 and Heart Diseases |
| Aneurysm, Dissecting | publications with TGFBR1 and Aneurysm, Dissecting |
| Colorectal Neoplasms | publications with TGFBR1 and Colorectal Neoplasms |
| Inflammation | publications with TGFBR1 and Inflammation |
| Lung Diseases | publications with TGFBR1 and Lung Diseases |
| Fibrosis | publications with TGFBR1 and Fibrosis |
| Neoplasms, Experimental | publications with TGFBR1 and Neoplasms, Experimental |
| Pain | publications with TGFBR1 and Pain |
| Lung Neoplasms | publications with TGFBR1 and Lung Neoplasms |
Organs/Tissues associated with TGFBR1 ELISA Kit
| Vascular | publications with TGFBR1 and Vascular |
| Connective Tissue | publications with TGFBR1 and Connective Tissue |
| Blood | publications with TGFBR1 and Blood |
| Muscle | publications with TGFBR1 and Muscle |
| Heart | publications with TGFBR1 and Heart |
| Lung | publications with TGFBR1 and Lung |
| Bone | publications with TGFBR1 and Bone |
| Skin | publications with TGFBR1 and Skin |
| Embryonic Tissue | publications with TGFBR1 and Embryonic Tissue |
| Kidney | publications with TGFBR1 and Kidney |